The synergistic effects of Apatinib combined with cytotoxic chemotherapeutic agents on gastric cancer cells and in a fluorescence imaging gastric cancer xenograft model

The synergistic effects of Apatinib combined with cytotoxic chemotherapeutic agents on gastric cancer cells and in a fluorescence imaging gastric cancer xenograft model

Jiuhuan Feng,1 Shukui Qin2 1Institute of First Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, China; 2Oncology Center of PLA, 81 Hospital Affiliated to Nanjing University of Chinese Medicine, Nanjing, China Introduction: Methylsulfonic apatinib (hereinafter referred to as Apat...

Full description

Bibliographic Details
Main Authors:	Feng JH, Qin SK
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-05-01
Series:	OncoTargets and Therapy
Subjects:	Gastric cancer Apatinib chemotherapy fluorescence imaging.
Online Access:	https://www.dovepress.com/the-synergistic-effects-of-apatinib-combined-with-cytotoxic-chemothera-peer-reviewed-article-OTT

Similar Items

Efficacy and safety of apatinib combined with chemotherapy for the treatment of advanced gastric cancer in the Chinese population: a systematic review and meta-analysis
by: Cheng HG, et al.
Published: (2018-07-01)

Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil
by: Xu Z, et al.
Published: (2019-05-01)

Effectiveness and safety of low‐dose apatinib in advanced gastric cancer: A real‐world study
by: Yingying Du, et al.
Published: (2020-07-01)

Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer
by: Ningning Li, et al.
Published: (2021-02-01)

Apatinib Combined With SOX Regimen in Conversion Treatment of Advanced Gastric Cancer: A Case Series and Literature Review
by: Dingyi Jiang, et al.
Published: (2020-07-01)

Concurrent apatinib and docetaxel vs apatinib monotherapy as third- or subsequent-line therapy for advanced gastric adenocarcinoma: a retrospective study
by: Lin H, et al.
Published: (2019-02-01)

Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer
by: Zaisheng Ye, et al.
Published: (2021-06-01)

Apatinib Suppresses Gastric Cancer Stem Cells Properties by Inhibiting the Sonic Hedgehog Pathway
by: Wanshuang Cao, et al.
Published: (2021-07-01)

Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study
by: Xinyang Liu, et al.
Published: (2017-09-01)

Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China
by: Peng W, et al.
Published: (2020-08-01)

Efficacy and safety assessment of apatinib in patients with advanced gastric cancer: a meta-analysis
by: Chen J, et al.
Published: (2018-07-01)

Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China [Corrigendum]
by: Peng W, et al.
Published: (2020-09-01)

A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients
by: Yang M, et al.
Published: (2019-10-01)

Experimental study of the vascular normalization window for tumors treated with apatinib and the efficacy of sequential chemotherapy with apatinib in lung cancer‐bearing mice and patients
by: Mingtao Liu, et al.
Published: (2020-04-01)

Efficacy and Safety of Apatinib in the Treatment of Postoperative Recurrence of Fibrosarcoma
by: Ma H, et al.
Published: (2020-02-01)

Efficacy of Conversion Surgery Following Apatinib Plus Paclitaxel/S1 for Advanced Gastric Cancer With Unresectable Factors: A Multicenter, Single-Arm, Phase II Trial
by: Zhiyuan Xu, et al.
Published: (2021-03-01)

Efficacy and Safety of Apatinib for Elderly Patients with Advanced or Metastatic Gastric Cancer After Failure of at Least First-Line Chemotherapy: A Multi-Center, Single-Arm, Phase II Study
by: Ren D, et al.
Published: (2021-08-01)

Efficacy and safety of apatinib treatment for gastric cancer, hepatocellular carcinoma and non-small cell lung cancer: a meta-analysis
by: Xue J, et al.
Published: (2018-09-01)

Salvage treatment with apatinib for advanced non-small-cell lung cancer
by: Song Z, et al.
Published: (2017-03-01)

Successful treatment of angiosarcoma of the scalp with apatinib: a case report
by: Ji G, et al.
Published: (2016-08-01)

Pyrotinib treatment on HER2-positive gastric cancer cells promotes the released exosomes to enhance endothelial cell progression, which can be counteracted by apatinib
by: Gao Z, et al.
Published: (2019-04-01)

Multiline treatment combining apatinib with toptecan for platinum-resistant recurrent ovarian cancer patients: a report of three cases
by: Cheng Y, et al.
Published: (2018-04-01)

Apatinib treatment combined with chemotherapy for advanced epithelial ovarian cancer: a case report
by: Deng L, et al.
Published: (2017-03-01)

Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma
by: Jingjing Ge, et al.
Published: (2021-02-01)

Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case Report
by: Le-Tian Huang, et al.
Published: (2019-12-01)

Effect of Apatinib on Invasion and Migration of Lung Cancer Cells and Its Mechanism
by: Yin YUAN, et al.
Published: (2019-05-01)

Effectiveness and Safety of Apatinib in Patients with Advanced or Metastatic Adenocarcinoma of Stomach or Gastroesophageal Junction: A Prospective Observation Study
by: Shen B, et al.
Published: (2020-05-01)

Progress of Apatinib in Treatment of Non-small Cell Lung Cancer
by: LIANG Lijun, et al.
Published: (2018-11-01)

Research Progress on Antitumor Mechanism of Apatinib
by: ZHAO Lingying, et al.
Published: (2021-01-01)

Therapeutic Effect of Apatinib in First-line Treatment of Advanced Liver Cancer
by: KE Shaobo, et al.
Published: (2021-07-01)

Safety and efficacy of combination therapy with apatinib and doxorubicin in metastatic soft tissue sarcomas: an observational study from multiple institutions
by: Tian Z, et al.
Published: (2019-06-01)

Successful treatment of advanced malignant fibrous histiocytoma of the right forearm with apatinib: a case report
by: Ji GH, et al.
Published: (2016-02-01)

Clinical effect and safety of transarterial chemoembolization combined with apatinib in treatment of advanced primary liver cancer
by: WU Jian, et al.
Published: (2018-04-01)

Apatinib for patients with advanced or recurrent cervical cancer: study protocol for an open-label randomized controlled trial
by: Jian-Guo Zhou, et al.
Published: (2018-09-01)

Remarkable Response of Metastatic Gallbladder Carcinoma to Apatinib After Failed Multiline Chemotherapies: A Case Report and Literature Review
by: Mengxi Zhang, et al.
Published: (2019-11-01)

Apatinib-loaded lipid nanobubbles combined with ultrasound-targeted nanobubble destruction for synergistic treatment of HepG2 cells in vitro
by: Tian Y, et al.
Published: (2018-08-01)

Traditional Chinese medicine Astragalus polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on proliferation, invasiveness, and apoptosis
by: Wu J, et al.
Published: (2018-05-01)

INTRAOPERATIVE FLUORESCENCE DIAGNOSIS OF PERITONEAL DISSEMINATION IN PATIENTS WITH GASTRIC CANCER
by: E. A. Suleymanov, et al.
Published: (2016-12-01)

Tumor-infiltrating γδT cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer
by: Jieti Wang, et al.
Published: (2017-11-01)

The Safety and Efficacy of Camrelizumab and Its Combination With Apatinib in Various Solid Cancers
by: Kunlun Wang, et al.
Published: (2020-10-01)